Responding to emerging COVID-19 variants of concern

Information

Type

Guidance

Regulated products

Medical Devices

Topics

Coronavirus, Health And Social Care

Published

February 2, 2023

Last updated

February 2, 2023

Description

A set of principles for understanding the impact of new variants on antiviral drugs and monoclonal antibodies

Organization

Country / Region

United Kingdom

License

Open Government Licence 2.0 (United Kingdom)

Feedback

Suggest an improvement to this page

Actions

Social networks

Embed